You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CSCC

Showing 1 - 25 of 111
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Carcinoma Trial (MK-3475A)

Not yet recruiting
  • Squamous Cell Carcinoma
  • MK-3475A
  • (no location specified)
Sep 11, 2023

Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck Trial in Tucson, Tampa

Terminated
Has Results
  • Cutaneous Squamous Cell Carcinoma
  • Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • Tucson, Arizona
  • +1 more
Nov 2, 2022

Squamous Cell Carcinoma Trial in Pittsburgh (Pembrolizumab Injection)

Recruiting
  • Squamous Cell Carcinoma
  • Pembrolizumab Injection
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jun 21, 2022

Cutaneous Squamous Cell Carcinoma Trial in Guangzhou (HLX07)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Jun 15, 2022

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +2 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023

Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Advanced Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Cutaneous Squamous Cell Carcinoma, Skin Cancers - Squamous Cell Carcinoma Trial in Pittsburgh (Microneedle Array Doxorubicin

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Skin Cancers - Squamous Cell Carcinoma
  • Microneedle Array Doxorubicin (MNA-D)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Nov 28, 2022

Heart Failure Trial in Copenhagen Ø (Cardiology Stem Cell Centre Adipose Stem Cell (CSCC_ASC), Placebo)

Completed
  • Heart Failure
  • Cardiology Stem Cell Centre Adipose Stem Cell (CSCC_ASC)
  • Placebo
  • Copenhagen Ø, Denmark
    Cardiac Catheterization Laboratory 2014, The Heart Centre, Unive
Sep 2, 2022

Use of Cemiplimab in Adult Patients in UK

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • No intervention
  • Reading, Berkshire, United Kingdom
    Sanofi-Aventis UK
Aug 7, 2022

SSC Trial in Worldwide (IFX-1, IFX-1 + pembrolizumab combination therapy)

Recruiting
  • SSC
  • IFX-1
  • IFX-1 + pembrolizumab combination therapy
  • La Jolla, California
  • +24 more
Nov 10, 2022

Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (Cemiplimab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Redwood City, California
  • +8 more
Mar 28, 2022

Locally Advanced Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Unresectable Skin Squamous Cell

Recruiting
  • Locally Advanced Skin Squamous Cell Carcinoma
  • +2 more
  • Atezolizumab
  • Stereotactic Body Radiation Therapy
  • Duarte, California
    City of Hope Medical Center
Aug 2, 2022

Decisional Conflicts, Health-related QoL and Satisfaction With

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +9 more
  • Regular care with additionally administration of questionnaires
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Jul 28, 2022

High-risk cSCC Treated With Surgery and Radiotherapy

Not yet recruiting
  • Squamous Cell Carcinoma of the Skin
  • Peripheral blood sampling in order to evaluate changes in the circulating immune population
  • (no location specified)
Feb 15, 2022

Lung Transplant Rejection Trial in Copenhagen (adipose derived mesenchymal stromal cells, Saline)

Recruiting
  • Lung Transplant Rejection
  • adipose derived mesenchymal stromal cells
  • Saline
  • Copenhagen, Denmark
    2014 Department of Cardiology, The Heart Centre, University Hosp
Jul 12, 2021

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • Duarte, California
  • +12 more
Sep 21, 2022

Heart Failure Trial in Copenhagen (CSCC_ASC)

Completed
  • Heart Failure
  • CSCC_ASC
  • Copenhagen, Denmark
    2014 Department of Cardiology, The Heart Centre, University Hosp
Jan 15, 2021

Non-ischemic Dilated Cardiomyopathy Trial in Copenhagen (Allogeneic adipose-derived stromal cells (CSCC_ASC), Control group)

Recruiting
  • Non-ischemic Dilated Cardiomyopathy
  • Allogeneic adipose-derived stromal cells (CSCC_ASC)
  • Control group
  • Copenhagen, Denmark
    The Heart Centre, Rigshospitalet University Hospital Copenhagen,
Jan 15, 2021

Cutaneous Squamous Cell Carcinoma Trial in Australia, Germany, United States (Cemiplimab)

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Palo Alto, California
  • +21 more
Apr 5, 2022

Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial

Not yet recruiting
  • Basal Cell Carcinoma
  • Cutaneous Squamous Cell Carcinoma
    • (no location specified)
    Feb 14, 2023

    Squamous Cell Carcinoma, RP1 Trial (RP1)

    Not yet recruiting
    • Squamous Cell Carcinoma
    • RP1
    • (no location specified)
    May 4, 2023

    Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne

    Not yet recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +3 more
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    May 17, 2023

    Advanced Cutaneous Squamous Cell Carcinoma Trial in Worldwide (cemiplimab)

    Active, not recruiting
    • Advanced Cutaneous Squamous Cell Carcinoma
    • Phoenix, Arizona
    • +77 more
    Jan 4, 2023

    CemiplimAb Survivorship Epidemiology

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • Basal Cell Carcinoma
    • Huntsville, Alabama
    • +52 more
    Dec 14, 2022

    Melanoma (Skin), Squamous Cell Carcinoma of the Skin, Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (CV8102,

    Active, not recruiting
    • Melanoma (Skin)
    • +3 more
    • CV8102
    • CV8102 + anti-PD-1 therapy
    • Graz, Austria
    • +21 more
    Nov 3, 2021